Paradigm Research
Paradigm Research, LLC is a privately held, founder-owned clinical research organization providing project-based clinical operations and regulatory services to start-up medical device and biotech companies in the United States, using a scalable professional network and pay-for-what-you-need pricing.
- Company typePrivate
- Founded2019
- HeadquartersCupertino, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Paradigm Research does
Paradigm Research, LLC is a privately held, founder-owned clinical research organization (CRO) founded in 2019 by Meredith Mundy and headquartered in the Cupertino/San Jose, California area. The firm provides project-based clinical research services, including clinical operations and regulatory support, to start-up medical device and biotech companies in the United States.
The company's core offering is delivered through a scalable network model rather than a fixed employee base: it draws on a curated pool of clinical research professionals covering Clinical Operations through Regulatory functions and scales the team to the needs of each client project. There is no platform-plus-modules product architecture; the offering is a single unified clinical research service, supported by a Wix-hosted company website (paradigmcr.net) and a LinkedIn company page as the primary digital touchpoints. No patents, proprietary technology, AI/ML capabilities, or API/SDK surface are evidenced in the input.
Commercially, Paradigm Research operates a professional-services revenue model with quote-based, pay-for-what-you-need pricing and multi-year contracts, explicitly designed to avoid the fixed overhead typical of larger CROs. Go-to-market is direct and relationship-driven, targeting early-stage medical device and biotech sponsors that need to balance speed, quality, and cost. The company is bootstrapped with no disclosed outside investment, parent company, subsidiaries, partnerships, or acquisitions.
Paradigm Research firmographics
Firmographics- Name
- Paradigm Research
- Legal name
- Paradigm Research, LLC
- Website
- https://paradigmcr.net
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Paradigm Research, LLC is a privately held, founder-owned clinical research organization providing project-based clinical operations and regulatory services to start-up medical device and biotech companies in the United States, using a scalable professional network and pay-for-what-you-need pricing.
- Ownership category
- akta.pro rank
Paradigm Research industry classification
Industry- Product category
- Contract Research Organization (CRO) Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)
Keywords
Where Paradigm Research is headquartered
LocationHeadquarters
- HQ city
- Cupertino
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Paradigm Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Clinical Research Services: Project-based clinical research services for start-up medical device and biotech companies. Services are scaled to project needs with a flexible network of clinical research professionals. Clients pay only for needed services without traditional CRO overhead.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Flexible project-based pricing scaled to client needs |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Paradigm Research product offering
Product offeringCore offering
Paradigm Research, LLC is a Clinical Research Organization (CRO) that delivers scalable clinical research services tailored to start-up medical device and biotech companies. Services span Clinical Operations through Regulatory functions and are executed via a flexible network of clinical research professionals, allowing clients to pay only for the services they need on a project-by-project basis without the overhead typical of larger CROs.
Product overview
Paradigm Research is a Clinical Research Organization (CRO) that provides a single unified offering of clinical research services specifically designed for start-up medical device and biotech companies. The company offers scalable clinical research services that can be adjusted to project needs, with a network of clinical research professionals covering Clinical Operations to Regulatory functions. The company does not operate a platform-plus-modules architecture but rather delivers services through a flexible, pay-for-what-you-need model.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Research Services Scalable, project-based clinical research organization (CRO) services for start-up medical device and biotech companies, covering Clinical Operations through Regulatory functions. Services are delivered through a flexible network of clinical research professionals that is sized to project needs, with clients paying only for the services they require rather than for full-service CRO overhead.
Companies that use Paradigm Research
Customer profileSegments2 records
Ideal customer profiles2 records
Paradigm Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Paradigm Research partnerships and signals
Strategic signalScale indicators1 record
Recent moves3 records
Paradigm Research competitors and assessment
Company assessmentBroad incumbents
- Medpace: Large, publicly traded CRO with a strong mid-sized biotech and medical device focus. Operates in the same clinical research services category but at significantly larger scale and with a broader portfolio.
- ICON plc: Global, large-scale CRO offering end-to-end clinical development services. Comparable as a CRO competitor for biotech and medical device sponsors, though operating at vastly larger scale with technology-driven delivery.
- IQVIA: Largest global CRO and life sciences services provider with broad clinical operations and regulatory capabilities. Comparable as a CRO competitor but operates at significantly larger scale across all sponsor segments.
Direct peers
- Biorasi: Boutique CRO focused specifically on emerging biotech and small-to-mid sized sponsors, with a flexible engagement model. Highly comparable to Paradigm Research's start-up-focused CRO positioning and project-based delivery.
- CROMSOURCE: Mid-sized European-headquartered CRO serving biotech, medical device, and pharma clients of varying sizes. Comparable in service scope (clinical operations, regulatory, full-service delivery) and mid-market positioning.
- Synteract: Mid-sized CRO that historically focused on emerging and mid-sized biopharma and medical device companies. Similar service scope (clinical operations, regulatory) and similar target customer profile as Paradigm Research.
- Worldwide Clinical Trials: Mid-sized CRO with strong presence in biotech and emerging pharma, offering clinical operations and regulatory services. Comparable in customer segment focus and mid-tier CRO positioning.
- Premier Research: Mid-sized CRO with explicit focus on small and mid-sized biotech, medical device, and specialty pharma sponsors. Directly comparable in serving under-served early-stage sponsors with flexible clinical operations services.
- Celerion: Early-phase clinical research CRO serving biotech and pharma with a network-driven operational model. Comparable in its boutique CRO positioning and clinical operations focus.
- Rho: Mid-sized, full-service CRO with deep roots in serving small and emerging biopharma and medical device sponsors. Comparable to Paradigm in target customer segment (early-stage sponsors) and clinical operations/regulatory service scope.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Paradigm Research social profiles
Digital presenceParadigm Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Paradigm Research leadership team
Management profileNumber of profiles
Profiles1 record
Paradigm Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Paradigm Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Paradigm Research
What does Paradigm Research do?
Paradigm Research, LLC is a Clinical Research Organization (CRO) that delivers scalable clinical research services tailored to start-up medical device and biotech companies. Services span Clinical Operations through Regulatory functions and are executed via a flexible network of clinical research professionals, allowing clients to pay only for the services they need on a project-by-project basis without the overhead typical of larger CROs.
Is Paradigm Research a public or private company?
Paradigm Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Paradigm Research founded?
Paradigm Research was founded in 2019. It employs 1 to 10 people.
Where is Paradigm Research based?
Paradigm Research is headquartered in Cupertino, United States, in the North America region.
How does Paradigm Research make money?
One revenue line is on record: clinical Research Services.
Who are Paradigm Research's main competitors?
Broad incumbents on record are Medpace, ICON plc and IQVIA. Direct peers are Biorasi, CROMSOURCE, Synteract, Worldwide Clinical Trials, Premier Research, Celerion and Rho.
Does Paradigm Research have an API?
No public API is recorded for Paradigm Research.
What industry is Paradigm Research in?
Paradigm Research's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 54171 and its SIC code is 8731.